The new CEO has at least five years and a large M&A war chest to position Sanofi for life after the loss of exclusivity on ...

Rejuvenate Bio is a gene therapy startup that seeks to reverse aging. In response to emailed questions, CEO and Co-founder Daniel Oliver talked about how he and his co-founder started the company and ...

Michelle McMurry-Heath, M.D., has resigned as CEO of the Biotechnology Innovation Organization (BIO). The news comes just days after a report detailed clashes between her and the organization’s board.

A decade of research and validation positions the company for global scale as it formalizes its role as foundational health intelligence infrastructure. We are the infrastructure company for biometric ...

Pivot Bio, whose microbial nitrogen products have become increasingly popular, has announced that Chris Abbott will become its new Chief Executive Officer, replacing co-founder and now-former CEO ...

The CEO of the Biotech Innovation Organization (BIO), one of the top lobbying groups for the biopharma industry, is on leave amid internal dissent over her leadership, The Wall Street Journal reported ...

Boundless Bio, a clinical-stage oncology company focused on extrachromosomal DNA (ecDNA) to develop therapies for oncogene amplified cancers, announced that its CEO Zachary Hornby will participate in ...

Mr. Lisicki has extensive experience in the pharmaceutical industry, having held key leadership positions at pharmaceutical organizations of various sizes. "With a successful track record in strategy, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Uniquity Bio appoints Will Kane ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Most of Kelderman's pay was in ...